InvestorsHub Logo
Followers 5218
Posts 24047
Boards Moderated 5
Alias Born 09/20/2000

Re: None

Wednesday, 12/02/2009 1:02:42 AM

Wednesday, December 02, 2009 1:02:42 AM

Post# of 97239
docgreen951, to answer your PDMI questions…

To answer your questions from the post below…
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43816448

With the ParaMax, I’m not that familiar with that product either as it is something new that is supposed to revolutionize the glaucoma world. From my understanding from the conversation I had with him, the Paravue and ParaMax are devices that will make significant impacts within the industry. The Paravue is just one of four new ophthalmic diagnostic devices that are expected to have major impacts that are pending FDA approved. The Paravue device is going to allow for sophisticated topographer utilization of the Placido Disk Technology and advanced software to provide accurate and detailed analysis of the anterior corneal surface. To elaborate a little more…

Corneal topography -- also known as videokeratography or corneal mapping -- represents a significant advance in the measurement of the corneal curvature. Most corneal topographers evaluate 8,000 to 10,000 specific points across the entire corneal surface. By contrast, the Paravue processes more than 100,000 points. It also offers corneal wave front analysis with 2, 3 or 4 maps available for comparison. The Paravue provides both a qualitative and quantitative evaluation of corneal curvature. It does so by utilizing a big placido disk with 24 concentric rings, which project onto the cornea to create a virtual image. The device compares this image to the target size, and the computer then calculates the corneal curvature. Advanced features including advanced rings editing, variable scales, refractive power map and more make the Paravue a valuable tool in the optometric and ophthalmic clinics.
http://www.marketwire.com/press-release/Paradigm-Medical-Industries-Inc-997335.html

Now what you have just read is just for one of their devices… the Paravue. I think the ParaMax is something different. The ParaMax is supposed to revolutionize the industry even greater from my understanding in listening to the PDMI CEO and from going back over my notes.

From talking with the PDMI CEO, they apparently already have the market waiting in the wings along with the major company that is going to be a part of the team to support this product. All of them are waiting on the FDA approval as the CEO is very confident to soon be awarded to the company very soon. I am confident that they will be awarded FDA approval too simply because they know what is needed to be awarded such which is apparent by the amount of already FDA approved products indicated within the IBox:
http://investorshub.advfn.com/boards/board.aspx?board_id=4467

Of course, this will be the their largest and most important FDA approval awarded to date. He clearly made this known

This is an awesome piece of DD courtesy of Investor100 about glaucoma from the Glaucoma Research Foundation websites:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=42394049
http://www.glaucoma.org/news/on_world_sight.php
http://www.glaucoma.org

You spoke of the Rothchild Eye Institute located in Paris. PDMI delivered three of their ”Photon” systems to France of which one of those systems were used to perform a live surgery teaching Seminar at the prestigious Rothchild Eye Institute in Paris. They have plenty of clinical performance data which was required to obtain previous FDA clearance and to set the stage for this upcoming FDA approval to market their products. PDMI is really undervalued in my opinion for what I think they will be bringing to the industry. It did a lot for the credibility of PDMI just to have such a prominent known Institute as the Rothchild Eye Institute perform live surgery teaching Seminars in Paris using their Photon TM laser system:
http://www.rothchildeyeinstitute.com/

I am expecting this FDA Approval too any day now, as here are the requirements to obtain such from submitting a 501k for FDA Approval:
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/default.htm

With the time that has thus far elapse, PDMI is still on scheduled in my opinion for an announcement any day now for their FDA approval for their device/product and not for medicine. The length of time to get FDA Approval is much different and shorter for a device/product versus the length of time it takes to get FDA Approval for a drug or medicine which could take years. PDMI could get their FDA Approval on their device/product in 3 months or less which puts the approval being granted right around the Dec 2009 time frame or so. The key is to be positioned in PDMI before the announcement. PDMI is still trading like the calm before the storm.

You stated this below…

…I believe this could be a diamond in the rough - imagine if he is correct - this stock would be .30 - .75 easily and that is without the PARAVUE being introduced which by the way should happen before end of year and potentially could be another holy grail product to the eye world. …

I share a very similar enthusiasm as you have mentioned above. I think right now it is a lot of accumulating of shares waiting for such to happen. I think as we are now in Dec 2009, the accumulation should increase which might give the price of PDMI a chance to stabilize at or near the .01 per share area before any news is released just on the anticipation of the FDA approval news coming in Dec 2009. Heck, a little over a month ago, PDMI went to .0088 per share on no news with everyone knowing that Dec 2009 would be its impact month. I think the time is near.

When I spoke to the PDMI CEO, he never gave me a date for when news would be coming. He told me that he would start working on the PR for the announcement with a shareholder update for us. Still, he made it known that he did not want to release the update until he had received FDA approval of their ParaMax product of which he thought would be coming out soon. He spoke as if they had already received FDA approval of some other products that had not been announced yet which would be new to us too. He mentioned that everything would be in this upcoming big announcement after this one ParaMax FDA approval.

You also mentioned…

…BOTTOM LINE AT .004 - THE DOWNSIDE IS .002 - BUT the upside at a minimum is .03 - .75 no matter what share structure is out there (max as of now 1.4 bil)…

From going back through my notes again, I see where the PDMI CEO mentioned that he might increase the Authorized Shares (AS) a little to secure a huge amount of financing and grow the company to significant levels once the price is much higher. These shares used should be restricted. I don’t think it will matter if they get the FDA approval and as long as they don’t do a reverse split as he promised that the company ”would not” do. I asked a few times about the company doing a reverse split and he was very very adamant in stating that he is against the company doing any reverse split. He said that he is totally against it and always have been. He said that it’s nothing but a numbers game with changing the proportion of shares in relation to its price and only hurt the shareholders.

I must reiterate what I posted before about what he told me about the company not doing a reverse split. We had a great discussion on this matter because that was my #1 fear thinking that the company might do a reverse split since we talked about the OS being nearly maxed out. That also led me to think that the OS is 1.3 billion and some change since the AS is 1.4 billion shares. I had to hear how he viewed reverse splits since the company had just done one a little while ago back in Dec 2008 right before he had taken over PDMI. I definitely brought that to his attention. He further explained to me that the previous reverse split was not his idea as he did not want to do it. He said that the previous reverse split was already in place under the old management’s tenure and that there was nothing he could do about it to stop it from happening. He again assured me that we will not have to worry about the company doing a reverse split here.

You have my apology for just now responding as I was pulled in a few different directions over time and simply needed to make time to eventually organize these thoughts from my notes. Hopefully this helps to answer the your questions.

v/r
Sterling

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.